A recent proposal by Health and Human Services Secretary Robert Kennedy to discontinue the existing Covid vaccine recommendation for healthy pregnant women has sparked significant debate. Critics argue that this move could undermine decades of progress in safeguarding the health of pregnant individuals and their infants.

The proposal has been described as profoundly unethical, particularly given the historical exclusion of pregnant people from biomedical research and development.

Before the Covid pandemic, numerous reports highlighted the gap in evidence regarding pregnancy and called for ethical strategies to generate data during pregnancy within existing research frameworks. The PREVENT project, initiated in response to the Zika epidemic, specifically addressed the ethical inclusion of pregnant women in the development and deployment of new vaccines for emerging pandemic threats.

Despite hopes that the Covid pandemic would mark a turning point, with Operation Warp Speed indemnifying vaccine developers from litigation, vaccine developers did not prioritize generating pregnancy-specific data. Consequently, many countries, including the U.S., initially excluded pregnant women from Covid-19 vaccine rollouts, despite objections from organizations like the American College of Obstetricians and Gynecologists.

As evidence emerged showing that pregnant individuals infected with Covid faced higher hospitalization rates and adverse pregnancy outcomes, the U.S.eventually designated pregnant women as a high-risk,high-priority group for vaccination. However, the initial delay had already caused significant harm and uncertainty.

The Covid vaccine, along with the flu vaccine, became a routine recommendation during pregnancy to protect both the pregnant individual and their newborn.

critics contend that Kennedy’s stance disrupts this progress, potentially endangering the health of pregnant people and infants. They argue that there is no new evidence to justify this reversal, noting that millions of pregnant women have received Covid mRNA vaccines without significant safety concerns. while prior Covid infection or vaccination may offer some protection, vaccination during pregnancy is still considered beneficial.

Vaccination during pregnancy can also enhance protection for infants through the transfer of antibodies via the placenta. Covid vaccination leads to a rapid increase in Covid antibodies, providing infants with greater protection during this critical period.

Treating healthy pregnant individuals differently from other high-risk groups, such as those with asthma or diabetes, is viewed as unethical. If the government continues to recommend Covid vaccines for individuals with these conditions, it is argued that pregnant women, who also face increased risks from Covid, should receive the same recommendation.

Denying infants the protection afforded by maternal vaccination is also considered unethical. Covid-19 in pregnancy elevates the risk of stillbirth and preterm birth. Infants under 6 months, who are too young for vaccination, rely on maternal antibodies for protection.

Requiring randomized clinical trials as a prerequisite for recommending Covid vaccines in pregnancy is seen as ethically problematic. It is argued that withholding an intervention of established benefit,such as the Covid vaccine,from research participants is not ethically permissible.